85 related articles for article (PubMed ID: 21118738)
1. Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis.
Siniscalchi A; Gallelli L; Tolotta GA; Loiacono D; De Sarro G
Clin Ther; 2010 Nov; 32(12):2030-4. PubMed ID: 21118738
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners.
Moss EL; Simpson JS; Pelletier G; Forsyth P
Psychooncology; 2006 Mar; 15(3):259-67. PubMed ID: 16041840
[TBL] [Abstract][Full Text] [Related]
3. Bupropion-SR in treatment of social phobia.
Emmanuel NP; Brawman-Mintzer O; Morton WA; Book SW; Johnson MR; Lorberbaum JP; Ballenger JC; Lydiard RB
Depress Anxiety; 2000; 12(2):111-3. PubMed ID: 11091936
[TBL] [Abstract][Full Text] [Related]
4. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.
Jamerson BD; Krishnan KR; Roberts J; Krishen A; Modell JG
Psychopharmacol Bull; 2003; 37(2):67-78. PubMed ID: 14566216
[TBL] [Abstract][Full Text] [Related]
5. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
Meca-Lallana JE; de Mingo-Casado P; Amorin-Díaz M; Martínez-Navarro ML; Barreiro AF
Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960
[TBL] [Abstract][Full Text] [Related]
6. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis associated fatigue during natalizumab treatment.
Putzki N; Yaldizli O; Tettenborn B; Diener HC
J Neurol Sci; 2009 Oct; 285(1-2):109-13. PubMed ID: 19560168
[TBL] [Abstract][Full Text] [Related]
8. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
Flachenecker P; Meissner H
Mult Scler; 2008 Mar; 14(2):274-7. PubMed ID: 18337428
[TBL] [Abstract][Full Text] [Related]
9. [Selective noradrenaline-dopamine reuptake inhibition (SNDRI). More latitude for antidepressive therapy].
MMW Fortschr Med; 2007 May; 149 Suppl 2():88-9. PubMed ID: 17724976
[No Abstract] [Full Text] [Related]
10. Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
Patterson F; Schnoll RA; Wileyto EP; Pinto A; Epstein LH; Shields PG; Hawk LW; Tyndale RF; Benowitz N; Lerman C
Clin Pharmacol Ther; 2008 Sep; 84(3):320-5. PubMed ID: 18388868
[No Abstract] [Full Text] [Related]
11. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
12. Bupropion: efficacy and safety in the treatment of depression.
Saiz Ruiz J; Gibert J; Gutiérrez Fraile M; Bobes J; Vallejo J; Iglesias C; Iriarte V
Actas Esp Psiquiatr; 2011; 39 Suppl 1():1-25. PubMed ID: 22983817
[No Abstract] [Full Text] [Related]
13. Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression.
McLaughlin T; Hogue SL; Stang PE
Am J Ther; 2007; 14(2):221-5. PubMed ID: 17414593
[TBL] [Abstract][Full Text] [Related]
14. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
[TBL] [Abstract][Full Text] [Related]
15. What's new in smoking cessation: Zyban.
Raymond E; Bahdai Z; Waters H; Kinzie S; Chan WL; Blake E; Evans MF; Chan D; Shaw E
Can Fam Physician; 1999 Mar; 45():633-4. PubMed ID: 10099802
[No Abstract] [Full Text] [Related]
16. Bupropion XL for the sustained treatment of trichotillomania.
Klipstein KG; Berman L
J Clin Psychopharmacol; 2012 Apr; 32(2):298-9. PubMed ID: 22388165
[No Abstract] [Full Text] [Related]
17. Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population.
Stang P; Suppapanaya N; Hogue SL; Park D; Rigney U
Am J Ther; 2007; 14(3):241-6. PubMed ID: 17515697
[TBL] [Abstract][Full Text] [Related]
18. A randomized crossover study of bee sting therapy for multiple sclerosis.
Wesselius T; Heersema DJ; Mostert JP; Heerings M; Admiraal-Behloul F; Talebian A; van Buchem MA; De Keyser J
Neurology; 2005 Dec; 65(11):1764-8. PubMed ID: 16221950
[TBL] [Abstract][Full Text] [Related]
19. Bupropion.
Nurs Times; 2006 Jan 3-9; 102(1):31. PubMed ID: 16425753
[No Abstract] [Full Text] [Related]
20. Better patient persistence with once-daily bupropion compared with twice-daily bupropion.
Stang P; Young S; Hogue S
Am J Ther; 2007; 14(1):20-4. PubMed ID: 17303971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
